The Nasdaq announced Monday that Moderna will be added to its Nasdaq 100 index in July. Moderna’s shares rose as much as 18% on Monday. On Monday, Jefferies kicked off Moderna’s coverage with a “buy” rating and a target price of $ 90 over the approval potential of the pharmaceutical …
Read More »Moderna rises 18% according to the report that the shares will join the Nasdaq 100 and, as the analyst predicts an increase of 45%
